Medeon Biodesign, Inc. (TPEX:6499)
Taiwan · Delayed Price · Currency is TWD 94.60
-3.20 (-3.27%)
At close: Dec 5, 2025
Medeon Biodesign Market Cap
Medeon Biodesign has a market cap or net worth of 8.73 billion as of December 5, 2025. Its market cap has increased by 108.14% in one year.
Market Cap
8.73B
Enterprise Value
7.99B
Revenue
381.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
94.60
Market Cap Chart
Since December 11, 2014, Medeon Biodesign's market cap has increased from 5.77B to 8.73B, an increase of 51.25%. That is a compound annual growth rate of 3.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 8.73B | 138.85% |
| Dec 31, 2024 | 3.65B | -14.91% |
| Dec 29, 2023 | 4.29B | -15.67% |
| Dec 30, 2022 | 5.09B | -22.76% |
| Dec 30, 2021 | 6.59B | 80.99% |
| Dec 31, 2020 | 3.64B | -13.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 283.81B |
| PharmaEssentia | 191.95B |
| Lotus Pharmaceutical | 78.89B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Oneness Biotech | 33.97B |
| Lin BioScience | 33.46B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 27.88B |